Bill Search

  • Introduced
    Feb 24, 2021
  • Passed Senate
  • Passed House
  • Signed into Law
    Apr 23, 2021
S 415
United States Senate Bill
Did you know we offer free bill tracking in Congress and 50 states, and a great mobile app? Sign up here
A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the scope of new chemical exclusivity.
Last Action See all actions
House • Apr 23, 2021: Became Public Law No: 117-9.

Official Summary/Bill Text

Comments on S 415

Tweets

Whip Lists

Sponsors
Votes
Looks like there aren't any voting records available at this moment.
Actions
  • Apr 23, 2021 | House
    • Signed by President.
    • Became Public Law No: 117-9.
  • Apr 20, 2021 | House
    • Presented to President.
  • Apr 14, 2021 | House
    • Mr. Pallone moved to suspend the rules and pass the bill.
    • Considered under suspension of the rules. (consideration: CR H1755-1756)
    • DEBATE - The House proceeded with forty minutes of debate on S. 415.
    • Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H1755)
    • On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H1755)
    • Motion to reconsider laid on the table Agreed to without objection.
  • Mar 12, 2021 | House
    • Received in the House.
    • Held at the desk.
  • Mar 11, 2021 | Senate
    • Message on Senate action sent to the House.
  • Mar 10, 2021 | Senate
    • Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.(consideration: CR S1435)
    • Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent. (consideration: CR S1435)
    • Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.(text: CR S1435)
    • Passed Senate without amendment by Unanimous Consent. (text: CR S1435)
  • Feb 24, 2021 | Senate
    • Introduced in Senate
    • Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Documents
Looks like we don't have any documents available at this moment.